Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Next-generation Sequencing

Next-generation Sequencing

The first human genome sequencing project cost $2.7 billion and was declared complete in 2003, after 15 years of international cooperation and collaboration between several research teams and funding agencies. Today, with the advent of next-generation sequencing technologies, the cost and time of sequencing a human genome have dropped over 100 fold.
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features....

Issues And Trends In Healthcare Delivery System

Issues And Trends In Healthcare Delivery System

The issues and trends in healthcare delivery are constantly changing. The COVID-19 pandemic is one recent issue that wreaked havoc on healthcare systems, causing a shortage of healthcare workers, high demand for medicines and supplies, and increased medical expenditure due to a lack of insurance. Other issues include rising healthcare costs and care fragmentation.
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...

Sanger Sequencing

Sanger Sequencing

DNA sequencing is a fundamental technique that is routinely used in the biological sciences. This method can be applied to a range of questions at different scales - from the sequencing of a cloned DNA fragment or the study of a mutation in a gene up to whole-genome sequencing. However, despite the widespread use of sequencing today, it was not until 1977 that Fredrick Sanger and his collaborators developed the chain-termination method to decode DNA sequences. It relies on the separation of a...

Preclinical Development: Overview

Preclinical Development: Overview

Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...

Predicting Reaction Outcomes

Predicting Reaction Outcomes

Kinetics describes the rate and path by which a reaction occurs. In contrast, thermodynamics deals with state functions and describes the properties, behavior, and components of a system. It is not concerned with the path taken by the process and cannot address the rate at which a reaction occurs. Although it does provide information about what can happen during a reaction process, it does not describe the detailed steps of what appears on an atomic or a molecular level. On the other hand,...

Upward Impending Motion

Upward Impending Motion

A square-threaded screw jack is a mechanical device widely used for lifting heavy loads or applying considerable force. Its operation is based on converting the force applied at its handle into a torsional moment, causing the upward impending motion of the screw. This movement is accomplished by overcoming the static friction between the threads of the screw and the jack.
To better comprehend how a screw jack functions, consider the completely unraveled thread as a block in contact with the...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Clarifying chaotic embryos: emerging evidence.

Fertility and sterility·2025

Same author

Cumulative pretrigger progesterone levels are not superior to single-day levels for predicting a failed cycle in fresh embryo transfer cycles.

Fertility and sterility·2025

Same author

An update on epigenetic mechanisms in endometriosis.

Minerva obstetrics and gynecology·2024

Same author

Initiation and outcomes of women pursuing planned fertility preservation.

Fertility and sterility·2024

Same author

Spontaneous conception in a 40-year-old woman after allogeneic stem cell transplant with active graft-versus-host disease: A case report.

Case reports in women's health·2024

Same author

Gonadotropin-Releasing Hormone (GnRH) Agonists Do Not Protect Ovarian Function in Patients Undergoing Stem Cell Transplants.

Cureus·2024

Same journal

Obstetric Care for Patients With Cognitive Disabilities.

Clinical obstetrics and gynecology·2026

Same journal

Dissecting the Americans With Disabilities Act (ADA) Requirements when Approaching Obstetric Patients With Disabilities: How to Ensure Your Spaces are Accessible for All.

Clinical obstetrics and gynecology·2026

Same journal

Clinician Comfort and Barriers to the Obstetric and Gynecologic Care of Patients With Disabilities.

Clinical obstetrics and gynecology·2026

Same journal

Obstetric Care for Patients With Visual Impairments: Preconception Counseling Through Postpartum Care.

Clinical obstetrics and gynecology·2026

Same journal

Menstrual Management and Contraception for Patients With Disabilities.

Clinical obstetrics and gynecology·2026

Same journal

Favoring Elective Hospitalization in Pregnancies With Vasa Previa.

Clinical obstetrics and gynecology·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Feb 25, 2026

Using Generative Art to Convey Past and Future Climate Transitions

Using Generative Art to Convey Past and Future Climate Transitions

Published on: March 31, 2023

Summary of Future Developments.

Jessica R Zolton¹, Alan Decherney

¹Eunice Kennedy Shriver, National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland.

Clinical Obstetrics and Gynecology

|July 26, 2017

Summary

This summary is machine-generated.

Endometriosis, a chronic disease impacting fertility, requires new treatments beyond current hormonal therapies. Future research into genetic and inflammatory pathways promises targeted, individualized therapies for endometriosis management.

More Related Videos

Development of New Therapeutic Applications Using Microfluidics

Development of New Therapeutic Applications Using Microfluidics

Published on: October 1, 2007

Related Experiment Videos

Last Updated: Feb 25, 2026

Using Generative Art to Convey Past and Future Climate Transitions

Using Generative Art to Convey Past and Future Climate Transitions

Published on: March 31, 2023

Development of New Therapeutic Applications Using Microfluidics

Development of New Therapeutic Applications Using Microfluidics

Published on: October 1, 2007

Area of Science:

Reproductive medicine
Molecular biology
Genetics

Background:

Endometriosis is a chronic condition causing infertility and pelvic pain.
Current treatments include surgery and hormonal therapies targeting estrogen and progesterone.
Hormonal treatments have side effects and contraindications, limiting options.

Purpose of the Study:

To explore emerging therapeutic strategies for endometriosis.
To highlight the role of genetic and inflammatory pathways in disease development.
To discuss advancements in pharmacologic agents for endometriosis management.

Main Methods:

Review of current and emerging endometriosis treatments.
Investigation of genetic factors and molecular pathways involved in pathogenesis.
Analysis of novel pharmacologic agents like selective progesterone receptor modulators and aromatase inhibitors.

Main Results:

Identification of specific genes involved in endometriosis development.
Understanding inflammatory pathways that promote ectopic endometrial growth.
Emergence of new drug classes offering improved management options.

Conclusions:

Future endometriosis therapies will likely be targeted and individualized.
Genomic studies and molecular pathway research are key to advancing treatment.
A deeper understanding of endometriosis pathogenesis will lead to better clinical outcomes.